Pharmacology, Toxicology and Pharmaceutical Science
Sunitinib
95%
Cardiotoxicity
78%
Mitogenic Agent
66%
S-Nitroso-N-Acetylpenicillamine
50%
Nicorandil
50%
Hazard Identification
50%
Phosphotransferase
50%
Brain Ischemia
50%
Ipratropium Bromide
50%
Assessment Factor
50%
Biological Marker
50%
Doxorubicin
50%
2 [4 (2 Carboxyethyl)phenethylamino]adenosine 5' (N Ethylcarboxamide)
50%
Glimepiride
50%
Piclidenoson
50%
Safety Pharmacology
50%
microRNA
45%
Adenosine 5' (N Ethylcarboxamide)
41%
Diazoxide
37%
Gliclazide
35%
Drug
33%
Adverse Drug Reaction
33%
Glibenclamide
33%
Adenosine Receptor Stimulating Agent
33%
Mitochondrial Permeability Transition Pore
31%
Mitogen Activated Protein Kinase 3
30%
Wortmannin
30%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
30%
Adenosine A3 Receptor Agonist
30%
Protein Kinase
29%
Stunned Heart Muscle
28%
2 Chloro 6 N Cyclopentyladenosine
27%
Atenolol
25%
Verapamil
25%
Digoxin
25%
Adenosine Derivative
25%
Drug Safety
25%
Messenger RNA
25%
Isoprenaline
25%
Flecainide
25%
Receptor
25%
Decanoic Acid
21%
Phosphotransferase Inhibitor
20%
Noradrenalin
19%
Acetylcholine
18%
Apoptosis Signal Regulating Kinase 1
18%
Heart Failure
16%
Namodenoson
16%
Tacrolimus
16%
Atractyloside
16%
Medicine and Dentistry
COVID-19
100%
Myocyte
100%
Patient
97%
Cardiovascular System
68%
Development
51%
Brain Ischemia
50%
Phosphoinositide 3-Kinase
50%
Glimepiride
50%
Doxorubicin
50%
Heart Atrium Function
50%
Middle Age
50%
Physical Activity
50%
Randomized Controlled Trial
50%
Older Adult
50%
Fatigue
50%
Systematic Review
50%
Left Ventricular Assist Device
50%
Meta-Analysis
50%
Ischemic Preconditioning
41%
Diazoxide
37%
Piclidenoson
35%
Atrium
33%
Glibenclamide
33%
Cardiotoxicity
31%
Cyclosporine
30%
Myocardial Stunning
28%
Myocardial Protection
25%
Caspase Inhibitor
25%
Heart Protection
25%
Heart
24%
Decanoic Acid
21%
Adverse Effect of Drug
20%
Fibrosis
20%
Heart Injury
18%
Cardiac Dysrhythmia
18%
Namodenoson
16%
Antiapoptotic
16%
Reperfusion Therapy
16%
Adenosine Triphosphate Sensitive Potassium Channel
16%
Ventricle of Heart
16%
Action Potential
16%
Left Atrium
16%
Left Ventricle
16%
Tissues
16%
Heart Surgery
16%
Isotopes of Calcium
16%
Tiopronin
14%
Channel Blocker
14%
Rhodium
14%
Sleep
13%
Biochemistry, Genetics and Molecular Biology
Doxorubicin
50%
Sunitinib
50%
Tachycardia
50%
Glimepiride
50%
Reoxygenation
50%
Heart Atrium Function
50%
Development
50%
Feedback System
50%
Ischemic Preconditioning
41%
Caspase 3
40%
Diazoxide
37%
Glibenclamide
33%
Cyclosporins
30%
Adenosine Receptor Agonist
30%
Reduction (Chemistry)
25%
Calcium
25%
Experiment
25%
Guinea Pig
21%
Kinase
20%
ATP-Sensitive Potassium Channel
16%
Action Potential
16%
Cardiac Muscle Cell
12%
Protein Kinase C
12%
Drug Safety
12%
RNA
12%
Rat
12%
Sulfonylurea
12%
Metabolic Pathway
12%
Kinetics
12%
Sensitivity Analysis
12%
Heart Muscle Contractility
10%
Calcium Homeostasis
10%
Cardiac Troponin
10%
Caspase
10%
Adenosine A3 Receptor
10%
Heart Beat
8%
Dynamics
8%
Cycling
8%
Compliance (Physical)
8%
Degradation
8%
Heart Output
8%
Time
8%
Self Concept
8%
Isolated Heart
8%
Adenosine Receptor
8%
Annexin
8%
Propidium Iodide
8%
Troponin I
5%
Anaerobic Threshold
5%
